Surrozen Inc. (NASDAQ: SRZN)
$9.25
-0.0773 ( -0.83% ) 4.4K
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
Market Data
Open
$9.25
Previous close
$9.33
Volume
4.4K
Market cap
$30.46M
Day range
$9.05 - $9.68
52 week range
$4.50 - $16.19
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| nt | Quarterly Reports | 1 | Apr 02, 2024 |
| 8-k | 8K-related | 18 | Apr 02, 2024 |
| 8-k | 8K-related | 37 | Apr 01, 2024 |
| 8-k | 8K-related | 12 | Feb 07, 2024 |
| 4 | Insider transactions | 1 | Feb 07, 2024 |
| 8-k | 8K-related | 10 | Jan 18, 2024 |
| 4 | Insider transactions | 1 | Dec 18, 2023 |
| 4 | Insider transactions | 1 | Dec 18, 2023 |
| 4 | Insider transactions | 1 | Dec 18, 2023 |
| 8-k | 8K-related | 14 | Dec 13, 2023 |